Results 211 to 220 of about 121,777 (350)
Intravenous Immunoglobulin May Be an Effective Therapy for Refractory, Active Diffuse Cutaneous Systemic Sclerosis [PDF]
, 2014 Corrie L. Poelman +5 more
openalex +1 more source
The impact of intravenous immunoglobulin therapy on resource utilization associated with viral respiratory tract infections. [PDF]
Front ImmunolAzar A +5 more
europepmc +1 more source
Intravenous Immunoglobulin Therapy in Livedoid Vasculopathy: Retrospective Observation of Clinical Outcome and Patient's Activity Level. [PDF]
J Cutan Med Surg, 2021 Kofler K +3 more
europepmc +1 more source
Carrier‐free self‐assembled nanomedicine for combination‐therapy of acute myeloid leukemia
BMEMat, EarlyView.CPDS combines drugs with three different mechanisms of action to achieve a multi‐mechanism combination therapy for AML by directly killing tumor cells and activating anti‐tumor immunity. Abstract As the main acute myeloid leukemia (AML) clinical treatment, the chemotherapy alone cannot meet the clinical therapeutic needs due to the high heterogeneity ...
Meihong Chai +14 more
wiley +1 more source
Review of intravenous immunoglobulin replacement therapy trials for primary humoral immunodeficiency patients [PDF]
, 2012 Harry W. Schroeder +1 more
openalex +1 more source
Clinical false positives resulting from recent intravenous immunoglobulin therapy: case report. [PDF]
BMC Infect Dis, 2021 Suresh J, Kyle BD.
europepmc +1 more source
Cancer Nexus, EarlyView.ABSTRACT Lipid nanoparticles (LNPs) represent the most clinically advanced platform for RNA delivery and have enabled major breakthroughs in vaccines and gene therapies. However, their broader application is still limited by inefficient extrahepatic delivery, immunogenicity, and insufficient control over tissue‐ and cell‐specific targeting. This review
Yu Han +5 more
wiley +1 more source